HIGHLIGHTS
- who: Wenping Li from the Translational Biomarkers, Merck and Co, Inc, WP D, Sumneytown Pike, West Point, PA, USA Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein, GZ, Groningen have published the paper: PET/CT Imaging of 89Zr-N-sucDf-Pembrolizumab in Healthy Cynomolgus Monkeys, in the Journal: (JOURNAL)
- what: This study reports the in_vivo evaluation of 89Zr-N-sucDfpembrolizumab in healthy cynomolgus monkeys as a preliminary study of biodistribution and clearance, investigating the translatability of PET using 89Zr-radiolabeled antibody in patients. This is consistent with clinical studies indicating that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.